MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
VTRS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Viatris (VTRS) Ownership - Who owns Viatris?

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
1000 Mylan Boulevard
Phone
+1 724 514-1800
Employees
38000
Web
https://www.viatris.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
18.33B
P/E Ratio
236.20
Total Cash
2.4B
Projected Growth
0.15
Total Debt
14.61B
Revenue
14.56B
Risk (Beta)
1.00
Dividend Yield
0.03
Total Cash/Share
2.06
Total Debt/Equity
N/A
Revenue/Share
12.48 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
VTRS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for VTRS
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Details
Industry
N/A
Address
1000 Mylan Boulevard
Phone
+1 724 514-1800
Employees
38000
Web
https://www.viatris.com